|
1
|
IARC: World Cancer Report 2014. Stewart BW
and Wild CP: IARC; Lyon: 2014
|
|
2
|
Cancer Trends Progress Report. National
Cancer Institute, NIH, DHHS; Bethesda, MD: 2019, https://progressreport.cancer.gov
|
|
3
|
Zhao Y and Adjei AA: Targeting
angiogenesis in cancer therapy: Moving beyond vascular endothelial
growth factor. Oncologist. 20:660–673. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bielenberg DR and Zetter BR: The
contribution of angiogenesis to the process of metastasis. Cancer
J. 21:267–273. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cartland SP, Genner SW, Zahoor A and
Kayurma MM: Comparative evaluation of TRAIL, FGF-2 and
VEGF-A-induced angiogenesis in vitro and in vivo. Int J Mol Sci.
17:E20252016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
De Palma M, Biziato D and Petrova TV:
Microenvironmental regulation of tumour angiogenesis. Nat Rev
Cancer. 17:457–474. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Marech I, Leporini C, Ammendola M,
Porcelli M, Gadaleta CD, Russo E, De Sarro G and Ranieri G:
Classical and non-classical proangiogenic factors as a target of
antiangiogenic yherapy in tumor microenvironment. Cancer Lett.
380:216–226. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Banys-Paluchoothtwski M, Witzel I,
Riethdorf S, Pantel K, Rack B, Janni W, Fasching PA, Aktas B,
Kasimir-Bauer S, Hartkopf A, et al: The clinical relevance of serum
vascular endothelial growth factor (VEGF) in correlation to
circulating tumor cells and other serum biomarkers in patients with
metastatic breast cancer. Breast Cancer Res Treat. 172:93–104.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gyamfi J, Eom M, Koo JS and Choi J:
Multifaceted roles of interleukin-6 in adipocyte-breast cancer cell
interaction. Transl Oncol. 11:275–285. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Knüpfer H and Preiss R: Significance of
interleukin-6 (IL-6) in breast cancer (Review). Breast Cancer Res
Treat. 102:129–135. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tawara K, Scott H, Emathinger J, Ide A,
Fox R, Greiner D, LaJoie D, Hedeen D, Nandakumar M, Oler AJ, et al:
Co-expression of VEGF and IL-6 family cytokines is associated with
decreased survival in HER2 negative breast cancer patients:
Subtype-specific IL-6 family cytokine-mediated VEGF secretion.
Transl Oncol. 12:245–255. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Litmanovich A, Khazim K and Cohen I: The
role of interleukin-1 in the pathogenesis of cancer and its
potential as a therapeutic target in clinical practice. Oncol Ther.
6:109–127. 2018. View Article : Google Scholar
|
|
13
|
Balasubramanian SP, Azmy IA, Higham SE,
Wilson AG, Cross SS, Cox A, Brown NJ and Reed MW: Interleukin gene
polymorphisms and breast cancer: A case control study and
systematic literature review. BMC Cancer. 6:1882006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Koukourakis MI, Papazoglou D,
Giatromanolaki A, Bougioukas G, Maltezos E and Siviridis E: VEGF
gene sequence variation defines VEGF gene expression status and
angiogenic activity in non-small cell lung cancer. Lung Cancer.
46:293–298. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Watson CJ, Webb NJ, Bottomley MJ and
Brenchley PE: Identification of polymorphisms within the vascular
endothelial growth factor (VEGF) gene: Correlation with variation
in VEGF protein production. Cytokine. 12:1232–1235. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ray D, Mishra M, Ralph S, Read I, Davies R
and Brenchley P: Association of the VEGF gene with proliferative
diabetic retinopathy but not proteinuria in diabetes. Diabetes.
53:861–864. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hall SK, Perregaux DG, Gabel CA, Woodworth
T, Durham LK, Huizinga TW, Breedveld FC and Seymour AB: Correlation
of polymorphic variation in the promoter region of the
interleukin-1 beta gene with secretion of interleukin-1 beta
protein. Arthritis Rheum. 50:1976–1983. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Um JY, Rim HK, Kim SJ, Kim HL and Hong SH:
Functional polymorphism of IL-1 alpha and its potential role in
obesity in humans and mice. PLoS One. 6:e295242011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rana BK, Flatt SW, Health DD, Pakiz B,
Quintana EL, Natarajan L and Rock CL: The IL-6 gene promoter SNP
and plasma IL-6 in response to diet intervention. Nutrients.
9:E5522017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Boeta-Lopez K, Duran J, Elizondo D,
Gonzales E, Rentfro A, Schwarzbach AE and Nair S: Association of
interleukin-6 polymorphisms with obesity or metabolic traits in
young Mexican-Americans. Obes Sci Pract. 4:85–96. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sampaio AM, Balseiro SC, Silva MR, Alarcão
A, d'Aguiar MJ, Ferreira T and Carvalho L: Association between IL-4
and IL-6 expression variants and gastric cancer among portuguese
population. GE Port J Gastroenterol. 22:143–152. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Langsenlehner U, Hofmann G, Renner W,
Gerger A, Krenn-Pilko S, Thurner EM, Krippl P and Langsenlehner T:
Association of vascular endothelial growth factor--a gene
polymorphisms and haplotypes with breast cancer metastases. Acta
Oncol. 54:368–376. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Escala-Garcia M, Guo Q, Dörk T, Canisius
S, Keeman R, Dennis J, Beesley J, Lecarpentier J, Bolla MK, Wang Q,
et al: Genome-wide association study of germline variants and
breast cancer-specific mortality. Br J Cancer. 120:647–657. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Khan S, Fagerholm R, Kadalayil L, Tapper
W, Aittomäki K, Liu J, Blomqvist C, Eccles D and Nevanlinna H:
Meta-analysis of three genome-wide association studies identifies
two loci that predict survival and treatment outcome in breast
cancer. Oncotarget. 9:4249–4257. 2017.PubMed/NCBI
|
|
25
|
Peng X, Shi J, Sun W, Ruan X, Guo Y, Zhao
L, Wang J and Li B: Genetic polymorphisms of IL-6 promoter in
cancer susceptibility and prognosis: A meta-analysis. Oncotarget.
9:12351–12364. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Abana CO, Bingham BS, Cho JH, Graves AJ,
Koyama T, Pilarski RT, Chakravarthy AB and Xia F: IL-6 variant is
associated with metastasis in breast cancer patients. PLoS One.
12:e01817252017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
DeMichele A, Martin AM, Mick R, Gor P,
Wray L, Klein-Cabral M, Athanasiadis G, Colligan T, Stadtmauer E
and Weber B: Interleukin-6 −174G->C polymorphism is associated
with improved outcome in high-risk breast cancer. Cancer Res.
63:8051–8056. 2003.PubMed/NCBI
|
|
28
|
DeMichele A, Gray R, Horn M, Chen J,
Aplenc R, Vaughan WP and Tallman MS: Host genetic variants in the
interleukin-6 promoter predict poor outcome in patients with
estrogen receptor-positive, node-positive breast cancer. Cancer
Res. 69:4184–4191. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Markkula A, Simonsson M, Ingvar C, Rose C
and Jernström H: IL6 genotype, tumour ER-status, and treatment
predicted disease-free survival in a prospective breast cancer
cohort. BMC Cancer. 14:7592014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xia H, Chen Y, Meng J and Liang C: Effect
of polymorphisms on IL1A to cancer susceptibility: Evidence based
on 34,016 subjects. Artif Cells Nanomed Biotechnol. 47:3138–3152.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Grimm C, Kantelhardt E, Heinze G,
Polterauer S, Zeillinger R, Kölbl H, Reinthaller A and Hefler L:
The prognostic value of four interleukin-1 gene polymorphisms in
Caucasian women with breast cancer: A multicenter study. BMC
Cancer. 9:782009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Snoussi K, Strosberg AD, Bouaouina N, Ben
Ahmed S and Chouchane L: Genetic variation in pro-inflammatory
cytokines (interleukin-1beta, interleukin-1alpha and interleukin-6)
associated with the aggressive forms, survival, and relapse
prediction of breast carcinoma. Eur Cytokine Netw. 16:253–260.
2005.PubMed/NCBI
|
|
33
|
Hayes DF, Ethier S and Mippman ME: New
guidelines for reporting of tumor marker studies in breast cancer
research and treatment: REMARK. Breast Cancer Res Treat.
100:237–238. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
McShane LM, Altman DG, Sauerbrei W, Taube
SE, Gion M and Clark GM; Statistics Subcommittee of the NCI-EORTC
Working Group on Cancer Diagnostics, : Reporting recommendations
for tumor marker prognostic studies (REMARK). J Natl Cancer Inst.
97:1180–1184. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
1000 Genomes Project Consortium, ; Auton
A, Brooks LD, Durbin RM, Garrison EP, Kang HM, Korbel JO, Marchini
JL, McCarthy S, McVean GA and Abecasis GR: A global reference for
human genetic variation. Nature. 526:68–74. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Barrett JC, Fry B, Maller J and Daly MJ:
Haploview: Analysis and visualization of LD and haplotype maps.
Bioinformatics. 21:263–265. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Stephens M, Smith NJ and Donnelly P: A new
statistical method for haplotype reconstruction from population
data. Am J Hum Genet. 68:978–989. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Stephens M and Scheet P: Accounting for
decay of linkage disequilibrium in haplotype inference and
missing-data imputation. Am J Hum Genet. 76:449–462. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kumari N, Dwarakanath BS, Das A and Bhatt
AN: Role of interleukin-6 in cancer progression and therapeutic
resistance. Tumour Biol. 37:11553–11572. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Dethlefsen C, Højfeldt G and Hojman P: The
role of intratumoral and systemic IL-6 in breast cancer. Breast
Cancer Res Treat. 138:657–664. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Masjedi A, Hashemi V, Hojjat-Farsangi M,
Ghalamfarsa G, Azizi G, Yousefi M and Jadidi-Niaragh F: The
significant role of IL-6 and its signaling pathway in the
immunopathogenesis and treatment of breast cancer. Biomed
Pharmacother. 108:1415–1424. 2018. View Article : Google Scholar : PubMed/NCBI
|
